Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population

Obstetrics and Gynecology

Volumn 89, Issue 6, 1997, Pages 937-940

  Hsieh, T'sang T ^a   Hung, Tai H ^b   Hsu, Jenn J ^b   Shau, Wen Y ^b   Su, Ching W ^b   Hsieh, Fon J ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DOWN SYNDROME; FEMALE; FETUS OUTCOME; GONADOTROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN CARE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CONFIDENCE INTERVALS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FETAL DISEASES; HUMANS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; TAIWAN;

EID: 0030908429     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00151-8     Document Type: Article

References (16)

1. Hsu JJ, Hsieh TT, Hsieh FJ. Down syndrome screening in an Asian population using alphafetoprotein and free β-hCG: A report of the Taiwan Down Syndrome Screening Group. Obstet Gynecol 1996; 87:943-7.
2. Milunsky A, Jick SS, Bruell CL. Predictive values, relative risks, and overall benefits of high and low maternal serum AFP screening in singleton pregnancies: New epidemiologic data. Am J Obstet Gynecol 1989;161:291-7.
3. Katz UL, Chescheir NC, Cefalo RC. Unexplained elevations of maternal serum AFP. Obstet Gynecol Surv 1990;45:719-26.
4. Crandall BF, Robinson L, Grau P. Risks associated with an elevated maternal serum α-fetoprotein. Am J Obstet Gynecol 1991;165: 581-6.
5. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The association between unexplained second trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992; 80:83-5.
6. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, et al. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993;168:1825-7.
7. Wenstrom KD, Owen J, Boots LR, DuBard MB. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 1994;171:1038-41.
8. Benn PA, Horne D, Briganti S, Rodis JF, Clive JM. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 1996;87:217-22.
9. Hsieh TT, Hsu JJ, Chen CC, Chiu TH, Liou JD, Hsieh CC, et al. An analysis of birth weight by gestational age in Taiwan. J Formosan Med Assoc 1991;90:382-7.
10. Phelan JP, Smith CV, Broussard P, Small M. Amniotic fluid assessment with the four quadrant technique at 36-42 weeks' gestation. J Reprod Med 1987;32:540-2.
11. Salafia CM, Silberman L, Herrera NE, Mahoney JH. Placental pathology at term associated with elevated mid-trimester maternal serum α-fetoprotein. Am J Obstet Gynecol 1988;158:1064-6.
12. Perkes EA, Baim RS, Goodman KJ, Macri JN. Second trimester placental changes associated with elevated maternal serum α-fetoprotein. Am J Obstet Gynecol 1982;144:935-8.
13. Fox H. The effect of hypoxia on trophoblast in organ culture: A morphologic and autoradiologic study. Am J Obstet Gynecol 1970;107:1058-64.
14. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III. Williams Obstetrics. 19th ed. Norwalk, CT: Appleton and Lange, 1993.
15. Dungan JS, Shulman LP, Phillips OP, Simpson JL, Meyer NL, Grevengood C, et al. Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in absence of fetal aneuploidy. J Soc Gynecol Invest 1994;1:55-8.
16. Pergament E, Stein AK, Fiddler M, Cho NH, Kupferminc MJ. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol 1995;86:255-8.